Tags : Project Nexus

Cyclica and AUM Biosciences Collaborate to Develop Novel Cancer Therapies

Shots: Cyclica to receive up front, milestones upon completion of specific stages for Project Nexus. AUM to get right to develop & commercialize therapies resulting from Project Nexus The collaboration leverages AUM’s drug development expertise including its biomarker-driven approach with Cyclica’s AI-augmented and structure-based platform, Ligand Design and Ligand Express The companies will design molecules […]Read More